NCT00913835 2019-09-26A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian CancerEli Lilly and CompanyPhase 2 Completed125 enrolled 20 charts
NCT01840943 2015-12-23A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyXian-Janssen Pharmaceutical Ltd.Phase 3 Terminated32 enrolled 13 charts